Score Breakdown
Offering Ability
46
Cash Runway
95
Float Risk
0
Warrant Exposure
15
Convertible Debt
15
Dilution Forecast
⛈️
Warning
High probability of dilution event
model est. 53%
🔄 Reverse Split
model est. 70%
• 50-day avg $0.21 below $1 exchange minimum
• Only 0 months cash — financial pressure
💰 Capital Raise
model 55%
• Critical: only 0.2 months cash remaining
📉 Score Deterioration
model 10%
• Score in HIGH risk zone (65/100)
Market Data
Market Cap$377.97M
Shares Outstanding1.71B
Float1.61B
Cash$595.0K
Debt$54.07M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 86.6% shares (2026Q1 vs prior)
8 institutional holders · 406.6K shares
#1
KELLEHER FINANCIAL ADVISORS
200.0K shares
#2
VSM Wealth Advisory, LLC
80.6K shares
#3
Opus Capital Group, LLC
60.1K shares
+ 5 more holders Sign up free to view →
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest69.85M
Days to Cover10.8
% of Float4.3%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2025-12-31
xbrl
XBRL CONVERTIBLE
2025-12-31
EFFECT
EFFECT
2026-04-20
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual NWBO Dilution Snapshot
Northwest Biotherapeutics, Inc. (NWBO) has a DilutionScore of 65/100, rated High dilution risk. Score date: August 28, 2026.
- Stored outstanding warrants: 200,000.
- Recent SEC activity tracked for NWBO: EFFECT on 2026-04-20; xbrl on 2025-12-31; xbrl on 2025-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — HIGH Risk
Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles: